desloratadine genoptim 0,5 mg/ml roztwór doustny
synoptis pharma sp. z o.o. - desloratadinum - roztwór doustny - 0,5 mg/ml
desloratadine genoptim 5 mg tabletki powlekane
synoptis pharma sp. z o.o. - desloratadinum - tabletki powlekane - 5 mg
desloratadine dr. max 5 mg tabletki powlekane
dr. max pharma limited - desloratadinum - tabletki powlekane - 5 mg
desloratadine ratiopharm 0,5 mg/ml roztwór doustny
ratiopharm gmbh - desloratadinum - roztwór doustny - 0,5 mg/ml
desloratadine sopharma 5 mg tabletki powlekane
sopharma warszawa sp. z o.o. - desloratadinum - tabletki powlekane - 5 mg
desloratadine actavis 0,5 mg/ml roztwór doustny
actavis group ptc ehf. - desloratadinum - roztwór doustny - 0,5 mg/ml
desloratadine sopharma 0,5 mg/ml roztwór doustny
sopharma warszawa sp. z o.o. - desloratadinum - roztwór doustny - 0,5 mg/ml
azacitidine celgene
celgene europe bv - azacytydyna - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - Środki przeciwnowotworowe - azacitidine celgene is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification,aml with >30% marrow blasts according to the who classification.
azacitidine mylan
mylan ireland limited - azacytydyna - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - Środki przeciwnowotworowe - azacitidine mylan is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29% marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30% blasts and multi lineage dysplasia, according to world health organisation (who) classification,aml with > 30% marrow blasts according to the who classification.
desloratadine teva
teva b.v - desloratadyna - rhinitis, allergic, perennial; rhinitis, allergic, seasonal - leki przeciwhistaminowe do stosowania systemowego, - Дезлоратадин teva jest wskazany do łagodzenia objawów związanych z:alergicznym zapaleniem błony śluzowej nosa;pokrzywka.